Diffuse cutaneous mucinoses

Dermatologic Clinics

Volumn 20, Issue 3, 2002, Pages 493-501

  Jackson, Elise M ^a   English III, Joseph C ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIFIBROTIC AGENT; CLADRIBINE; CORTICOSTEROID; CYCLOSPORIN; DIMETHYL SULFOXIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYALURONIDASE; HYPOPHYSIS EXTRACT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEVOTHYROXINE; MELPHALAN; MUCIN; PSORALEN; THYROID HORMONE;

CLINICAL FEATURE; DISEASE CLASSIFICATION; ELECTRON BEAM; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MUCINOSIS; MYXEDEMA; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PUVA; REVIEW; SCLEREDEMA; SKIN DISEASE; SKIN LUPUS ERYTHEMATOSUS; CLASSIFICATION; PATHOLOGY;

HUMAN; HYPOTHYROIDISM; MUCINOSES; MYXEDEMA; PROGNOSIS; SCLEREDEMA ADULTORUM; SKIN DISEASES; HUMANS;

EID: 0035990792     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00017-7     Document Type: Review

References (56)

1. Massive cutaneous mucinosis associated with systemic lupus erythematosus
2. Scleredema revisited: A poststreptococcal complication
3. Paraproteinemia in patients with scleredema
4. The dermal mucinoses
5. Scleredema adultorum
6. Scleredema adultorum associated with IgG-kappa multiple myeloma: A case report and review of the literature
7. Scleredema of buschke associated with waldenström's magroglobulinaemia
8. Scleredema and smoldering myeloma
9. Systemic involvement of scleredema of Buschke associated with IgG-kappa paraproteinaemia
10. Monoclonal gammopathies and associated skin disorders
11. Benign monoclonal gammopathy - After 20 to 35 years of follow-up
12. Scleredema diabeticorum of Buschke confined to the thighs
13. Scleredema: A systemic disease
14. Scleredema adultorum: Not always a benign self-limited disease
15. Scleredema adultorum associated with a monoclonal gammopathy and generalized hyperpigmentation
16. Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia
17. Scleredema adultorum: Case report and demonstration of abnormal expression of extracellular matrix genes in skin fibroblasts in vivo and in vitro
18. Sclerederma and paraproteinemia: Enhanced collagen production and elevated Type 1 procollagen messenger RNA level in fibroblasts grown from fibrotic skin of a patient
19. Monoclonal gammopathy in scleredema: Observations in three cases
20. Scleredema associated with paraproteinemia treated by extracorporeal photopheresis
21. Cream PUVA therapy for scleredema adultorum
22. Bath-PUVA therapy in three patients with scleredema adultorum
23. Cyclosporine in scleredema
24. Plasma cell dyscrasias
25. Scleromyxedema
26. Scleromyxedema
27. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema
28. 'Doughnut sign' in scleromyxoedema
29. Laryngeal involvement in scleromyxedema: A case report
30. Fatal scleromyxedema: Report of a case and review of the literature
31. Ophthalmic findings in scleromyxedema
32. Fever, convulsions and coma in scleromyxedema: A "dermato-neuro syndrome"
33. The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis)
34. Scleromyxedema with dermato-neuro syndrome
35. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients
36. Reticular erythematous mucinosis associated with human immunodeficiency virus infection
37. Cutaneous mucinosis and HIV infection
38. Lichen myxedematosus serum stimulates human skin fibroblast proliferation
39. Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts
40. Reticular erythematous mucinosis syndrome: Review of the world literature and report of the syndrome in a prepubertal child
41. Reticular erythematous mucinosis syndrome
42. Reticular erythematous mucinosis syndrome
43. REM syndrome: Reticular erythematous mucinosis (round-cell erythematosus), a new entity?
44. Cutaneous lupus mucinosis: A review of our cases and the possible pathogenesis
45. Reticular erythematous mucinosis syndrome: Report of a case with positive immunofluorescence
46. Reticular erythematous mucinosis: Light and electron microscopy, immunofluorescence and histochemical findings
47. Reticular erythematous mucinosis syndrome and a monoclonal IgG kappa paraprotein - Is there an association?
48. Reticular erythematous mucinosis syndrome
49. Failure of reticular erythematous mucinosis to respond to cyclosporine
50. Adult hypothyroidism 1. Manifestations and clinical presentation
51. Cutaneous manifestations of thyroid disease
52. Alopecia of myxedema: Clinical response to levothyroxine sodium
53. Adult hypothyroidism 1. Causes, laboratory diagnosis, and treatment
54. Altered skin elastic fibers in hypothyroid myxedema and pretibial myxedema
55. Factors associated with mortality of myxedema coma: Report of eight cases and literature survey
56. Reticular erythematous mucinosis syndrome: An immediate therapeutic response to hydroxychloroquine sulphate